GCP
TXMD icon

GSA Capital Partners’s TherapeuticsMD TXMD Stock Holding History

GSA Capital Partners’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,170
Closed -$79K – 1807
2022
Q1 		$79K Buy
+4,170
New +$65.6K 0.01% 1318
2021
Q4 		– Sell
-5,870
Closed -$218K – 1811
2021
Q3 		$218K Sell
5,870
-673
-10% -$29.9K 0.02% 1196
2021
Q2 		$389K Sell
6,543
-2,963
-31% -$179K 0.04% 788
2021
Q1 		$637K Buy
9,506
+1,804
+23% +$141K 0.11% 238
2020
Q4 		$466K Buy
7,702
+5,956
+341% +$407K 0.08% 460
2020
Q3 		$138K Sell
1,746
-452
-21% -$36K 0.02% 1082
2020
Q2 		$137K Buy
2,198
+225
+11% +$13.1K 0.08% 434
2020
Q1 		$105K Sell
1,973
-1,922
-49% -$191K 0.03% 891
2019
Q4 		$471K Buy
3,895
+3,651
+1,496% +$525K 0.05% 695
2019
Q3 		$44K Buy
+244
New +$34.4K 0.01% 1331
2018
Q2 		– Sell
-2,354
Closed -$573K – 1940
2018
Q1 		$573K Buy
2,354
+1,726
+275% +$484K 0.03% 995
2017
Q4 		$190K Sell
628
-1,368
-69% -$381K 0.01% 1421
2017
Q3 		$528K Buy
+1,996
New +$577K 0.04% 939
2016
Q2 		– Sell
-812
Closed -$260K – 1925
2016
Q1 		$260K Buy
812
+494
+155% +$169K 0.02% 1376
2015
Q4 		$165K Buy
+318
New +$117K 0.01% 1677
2015
Q1 		– Sell
-315
Closed -$70K – 2214
2014
Q4 		$70K Sell
315
-567
-64% -$117K ﹤0.01% 1617
2014
Q3 		$205K Buy
+882
New +$222K 0.01% 1512

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GSA Capital Partners's TXMD Position: Q2 2022 in Review

GSA Capital Partners sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 4,170 shares — an estimated $79K sold.

GSA Capital Partners first reported a position in TXMD in Q3 2014 and held it in 17 quarters. The position peaked at $637K in Q1 2021. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • GSA Capital Partners reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • GSA Capital Partners sold 4,170 TherapeuticsMD shares in Q2 2022, an estimated $79K.
  • GSA Capital Partners first reported a position in TherapeuticsMD in Q3 2014 and held it in 17 quarters.
  • GSA Capital Partners's TherapeuticsMD position peaked at $637K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.